American Cancer Society Recommends Guardant Health’s Shield Blood Test in Updated Colorectal Cancer Screening Guidelines

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/13/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. MSFT
9. CRM
10. CRWV

Go back to American Cancer Society Recommends Guardant Health’s Shield Blood Test in Updated Colorectal Cancer Screening Guidelines

Guardant Health (GH) PT Raised to $160 at BTIG, Second Day in a Row

May 27, 2026 12:49 PM EDT

BTIG analyst Mark Massaro raised the price target on Guardant Health (NASDAQ: GH) to $160.00 (from $155.00) while maintaining a Buy rating.

Street Insider note: BTIG raised the PT yesterday to $155.00 from $145.00.

The analyst comments "This morning, the American Cancer Society (ACS), a... More